More About Me
Administrative TitleAssociate Professor of Medicine and Pediatrics and Faculty, Clinical Addiction Research and Education Unit, Boston University Chobanian and Avedisian School of Medicine
ResidencyInternal Medicine and Pediatrics, Alpert Medical School at Brown University
FellowshipAddiction Medicine, Boston University Medical Center
Board CertificationsAddiction Medicine, American Board of Preventive Medicine, Pediatrics, American Board of Pediatrics, Internal Medicine, American Board of Internal Medicine
Special InterestsSubstance use disorder, opioid use disorders
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
As the principal teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center is devoted to training future generations of healthcare professionals. Learn more about Boston University Chobanian & Avedisian School of Medicine.
Featured on HealthCity
Non-fatal opioid overdose is a leading risk for overdose death. Post-overdose outreach programs offer an opportunity to connect to help.
"It's frustrating… we have the tools to be able to offer people what they need but…we have systems that are restricting the…care that people deserve."
Eliminating stigma around addiction in family attitudes for all treatment options is crucial, study finds.
Recovery coach Tyshaun Perryman shared a candid story of his own father's experience of civil commitment for substance use treatment.
Despite advice from medical groups, nearly two-thirds of patients studied didn't receive medication for opioid use disorder.
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
Better health outcomes hinge on positive social support for young adults with SUD, but uninformed family members can unintentionally cause harm.
As the pandemic surges, the urgency of adjusting to find the most useful approach to SUD treatment in a critical population is growing.
Research highlights opportunity to intervene with adolescents, a group particularly vulnerable to addiction and overdose.